Children's Mercy Kansas City operates the largest pediatric kidney
transplant program in Missouri and Kansas. The transplant program
complements the nationally recognized pediatric dialysis program and is a
key component of the Division of Nephrology,
which ranks as one of the top 6 programs in the country by U. S.
News and World Report.
Kidney Transplant Staff
Our multidisciplinary team works with referring physicians before,
during and after a transplant to ensure effective continuity of
care for pediatric transplant recipients and their families. We
have established an outstanding national reputation for patient
care and outcomes.
Data obtained from the Scientific Registry of
Transplant Recipients (SRTR) provides evidence of pediatric patient
and graft (transplanted organ) survival rates at Children's Mercy
that exceed the national average.
- Multidisciplinary transplant team including pediatric specialists in Nephrology, Transplant Surgery, Urology and Anesthesiology
- Availability of transplant coordinator, physician and surgeon 24 hours per day, seven days a week
- Pharmacokinetic modeling of immunosuppressive medications
- Laparoscopic kidney donation
- Opportunity to participate in research protocols of new therapies for transplant recipients
- Transition program for transplant recipients
- Medically supervised summer cap experience for dialysis and transplant patients
- Ronald McDonald House or the Ronald McDonald Family Room accommodations for patient families
- Evaluation of immunosuppressive dosing regimens as part of our
quality improvement activities has resulted in modification of
medication administration schedules and more prompt achievement of
therapeutic drug levels.
- We are working with colleagues in the Center for Personalized
Medicine and Therapeutic Innovation to explore the influence of
genomic-based variations in patient drug metabolism characteristics
on individualized treatment regimens.
- Our program is a regular participant in national
industry-sponsored pharmaceutical studies. Current protocols are
addressing the use of erythropoietic stimulating agents, vitamin D
and anti-viral agents in transplant recipients.
- We are one of a select group of pediatric transplant programs
in the country participating in a study sponsored by the National
Institutes of Health of antihypertensive therapy in pediatric
- The transplant, dialysis and general nephrology programs are
active members of the North American Pediatric Renal Trials and
Collaborative Studies (NAPRTCS). Activities include data entry into
the transplant, dialysis and chronic kidney disease registries,
participation in the benchmarking project, and frequent patient
entry into prospective clinical trials.